| P2093 | author name string | Hiroyuki Honda | |
| | Kazunori Shimizu | |
| | Sumire Nagasaka | |
| | Riho Genma | |
| | Yuuki Gotou | |
| P2860 | cites work | Prevention of skeletal muscle atrophy in vitro using anti-ubiquitination oligopeptide carried by atelocollagen. | Q51009658 |
| | Rapid formation of functional muscle in vitro using fibrin gels. | Q51601207 |
| | Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. | Q52166108 |
| | The insulin-like growth factors | Q70643023 |
| | Dexamethasone-Induced Skeletal Muscle Atrophy Increases O-GlcNAcylation in C2C12 Cells | Q87009895 |
| | Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro | Q38748704 |
| | Microfluidic devices for construction of contractile skeletal muscle microtissues | Q38969454 |
| | Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes | Q39023192 |
| | Optimizing the structure and contractility of engineered skeletal muscle thin films | Q39158104 |
| | Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism | Q39429075 |
| | Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells | Q39529709 |
| | Rapid decrease in active tension generated by C2C12 myotubes after termination of artificial exercise | Q39625468 |
| | Functional evaluation of artificial skeletal muscle tissue constructs fabricated by a magnetic force-based tissue engineering technique. | Q39673536 |
| | Assembly of skeletal muscle cells on a Si-MEMS device and their generative force measurement | Q39770032 |
| | Novel method for fabrication of skeletal muscle construct from the C2C12 myoblast cell line using serum-free medium AIM-V. | Q39863475 |
| | Polyphenols prevent clinorotation-induced expression of atrogenes in mouse C2C12 skeletal myotubes. | Q39877135 |
| | Accelerated de novo sarcomere assembly by electric pulse stimulation in C2C12 myotubes | Q40147251 |
| | Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway | Q40490374 |
| | Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. | Q40767544 |
| | Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs | Q43159102 |
| | IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. | Q44853225 |
| | Drug-screening platform based on the contractility of tissue-engineered muscle. | Q46781309 |
| | Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes | Q47983891 |
| | Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts | Q24629251 |
| | Cellular and molecular mechanisms of muscle atrophy | Q27012762 |
| | Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro | Q27324593 |
| | Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues | Q30496172 |
| | Formation and optogenetic control of engineered 3D skeletal muscle bioactuators | Q30537019 |
| | Induction of functional tissue-engineered skeletal muscle constructs by defined electrical stimulation | Q30576880 |
| | Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture | Q30577387 |
| | Novel method for measuring active tension generation by C2C12 myotube using UV-crosslinked collagen film | Q33533594 |
| | Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. | Q33815629 |
| | Mechanistic investigation of adult myotube response to exercise and drug treatment in vitro using a multiplexed functional assay system | Q34626889 |
| | Hypoenergetic diet-induced reductions in myofibrillar protein synthesis are restored with resistance training and balanced daily protein ingestion in older men. | Q35572953 |
| | Resistance strength training exercise in children with spinal muscular atrophy | Q35864678 |
| | Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia | Q36820819 |
| | Evaluation systems of generated forces of skeletal muscle cell-based bio-actuators | Q38048477 |
| | Glucocorticoid-induced skeletal muscle atrophy | Q38117492 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dexamethasone | Q422252 |
| P577 | publication date | 2017-06-15 | |
| P1433 | published in | Bioengineering | Q27727186 |
| P1476 | title | Three-Dimensional Culture Model of Skeletal Muscle Tissue with Atrophy Induced by Dexamethasone | |
| P478 | volume | 4 | |